C12Y 103/05001
Succinate dehydrogenase
Official title: Succinate dehydrogenase (ubiquinone) (1.3.5.1)
C12Y103/05001 (Succinate dehydrogenase) appears on 10 US grants and 23 published applications in this corpus.
Search patents in C12Y- Granted patents
- 10
- Published applications
- 23
- Assignees
- 18
- Inventors
- 60
- Latest grant
- 14 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2011 | 0 | 1 |
| 2012 | 0 | 1 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 1 | 1 |
| 2016 | 1 | 1 |
| 2017 | 1 | 2 |
| 2018 | 0 | 3 |
| 2019 | 1 | 0 |
| 2020 | 1 | 3 |
| 2021 | 1 | 1 |
| 2022 | 0 | 3 |
| 2023 | 1 | 0 |
| 2024 | 2 | 3 |
| 2025 | 0 | 2 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Genetically modified microorganism for production of aspartic acid and downstream metabolites from aspartic acid as target substance, and method for producing target substance using same14 Apr 2026US 12,600,991 B2Green Earth Institute Co., Ltd.
- Methods of metabolic regulation of mitochondria for treating neural injury and neurological disorders18 Jun 2024US 12,011,426 B2The USA, as represented by the Secretary, Dept. of Health and Human Services
- Bioconversion of short-chain hydrocarbons to fuels and chemicals27 Feb 2024US 11,913,049 B2
- Use of SDHA as a prognostic marker and therapeutic target in uveal melanoma26 Sep 2023US 11,767,564 B2Board of Regents, The University of Texas System
- Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof12 Oct 2021US 11,141,456 B2Stealth BioTherapeutics Inc.
- Genetically engineered microorganism and method for producing succinate and method for making genetically engineered microorganism27 Aug 2026US 2026/0250723 A1National Yang Ming.Chiao Tung University
- Fusion protein targeting mitochondria, method of making and use thereof21 Aug 2025US 2025/0263451 A1University of Rochester
- Genetically modified microorganism and method for producing aspartic acid19 Jun 2025US 2025/0197901 A1DIC Corporation
- Bioconversion of Short-Chain Hydrocarbons to Fuels and Chemicals19 Sep 2024US 2024/0309417 A1
- Methods for preventing or treating conditions related to t cell mediated intestinal disorders14 Mar 2024US 2024/0082183 A1The Regents of the University of Michigan
Most cited
By later US patents
- Compositions and methods for producing podophyllotoxin derivatives2US 10,472,688 B2The Board of Trustees of the Leland Stanford Junior University · 2019
- Method for producing a target substance by fermentation2US 9,045,789 B2Ajinomoto Co., Inc. · 2015
- Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof1US 10,576,124 B2Stealth BioTherapeutics Inc. · 2020
- Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof1US 11,141,456 B2Stealth BioTherapeutics Inc. · 2021
- Live attenuated catfish vaccine and method of making1US 9,700,611 B2Mississippi State University · 2017